Search details
1.
Machine learning algorithm improves the detection of NASH (NAS-based) and at-risk NASH: A development and validation study.
Hepatology
; 78(1): 258-271, 2023 07 01.
Article
in English
| MEDLINE | ID: mdl-36994719
2.
Defining the serum proteomic signature of hepatic steatosis, inflammation, ballooning and fibrosis in non-alcoholic fatty liver disease.
J Hepatol
; 78(4): 693-703, 2023 04.
Article
in English
| MEDLINE | ID: mdl-36528237
3.
Improving Assessment of Drug Safety Through Proteomics: Early Detection and Mechanistic Characterization of the Unforeseen Harmful Effects of Torcetrapib.
Circulation
; 137(10): 999-1010, 2018 03 06.
Article
in English
| MEDLINE | ID: mdl-28974520
4.
Discovery and Validation of a Six-Marker Serum Protein Signature for the Diagnosis of Active Pulmonary Tuberculosis.
J Clin Microbiol
; 55(10): 3057-3071, 2017 10.
Article
in English
| MEDLINE | ID: mdl-28794177
5.
Validation of a blood protein signature for non-small cell lung cancer.
Clin Proteomics
; 11(1): 32, 2014.
Article
in English
| MEDLINE | ID: mdl-25114662
6.
Highly multiplexed proteomic platform for biomarker discovery, diagnostics, and therapeutics.
Adv Exp Med Biol
; 735: 283-300, 2013.
Article
in English
| MEDLINE | ID: mdl-23402035
7.
HFrEF subphenotypes based on 4210 repeatedly measured circulating proteins are driven by different biological mechanisms.
EBioMedicine
; 93: 104655, 2023 Jul.
Article
in English
| MEDLINE | ID: mdl-37327673
8.
Machine learning-based biomarker profile derived from 4210 serially measured proteins predicts clinical outcome of patients with heart failure.
Eur Heart J Digit Health
; 4(6): 444-454, 2023 Dec.
Article
in English
| MEDLINE | ID: mdl-38045440
9.
Biomarkers for staging fibrosis and non-alcoholic steatohepatitis in non-alcoholic fatty liver disease (the LITMUS project): a comparative diagnostic accuracy study.
Lancet Gastroenterol Hepatol
; 8(8): 714-725, 2023 Aug.
Article
in English
| MEDLINE | ID: mdl-36958367
10.
Proteomic signatures for identification of impaired glucose tolerance.
Nat Med
; 28(11): 2293-2300, 2022 11.
Article
in English
| MEDLINE | ID: mdl-36357677
11.
A proteomic surrogate for cardiovascular outcomes that is sensitive to multiple mechanisms of change in risk.
Sci Transl Med
; 14(639): eabj9625, 2022 04 06.
Article
in English
| MEDLINE | ID: mdl-35385337
12.
Serum Proteomics and Plasma Fibulin-3 in Differentiation of Mesothelioma From Asbestos-Exposed Controls and Patients With Other Pleural Diseases.
J Thorac Oncol
; 16(10): 1705-1717, 2021 10.
Article
in English
| MEDLINE | ID: mdl-34116230
13.
Impact of Kidney Function on the Blood Proteome and on Protein Cardiovascular Risk Biomarkers in Patients With Stable Coronary Heart Disease.
J Am Heart Assoc
; 9(15): e016463, 2020 08 04.
Article
in English
| MEDLINE | ID: mdl-32696702
14.
Mechanisms of Sodium-Glucose Cotransporter 2 Inhibition: Insights From Large-Scale Proteomics.
Diabetes Care
; 43(9): 2183-2189, 2020 09.
Article
in English
| MEDLINE | ID: mdl-32527800
15.
Coronary Artery Disease and Type 2 Diabetes: A Proteomic Study.
Diabetes Care
; 43(4): 843-851, 2020 04.
Article
in English
| MEDLINE | ID: mdl-31988066
16.
Genetic architecture of host proteins involved in SARS-CoV-2 infection.
Nat Commun
; 11(1): 6397, 2020 12 16.
Article
in English
| MEDLINE | ID: mdl-33328453
17.
Genetic architecture of host proteins interacting with SARS-CoV-2.
bioRxiv
; 2020 Jul 01.
Article
in English
| MEDLINE | ID: mdl-32637948
18.
Plasma protein patterns as comprehensive indicators of health.
Nat Med
; 25(12): 1851-1857, 2019 12.
Article
in English
| MEDLINE | ID: mdl-31792462
19.
The Impact of the Glomerular Filtration Rate on the Human Plasma Proteome.
Proteomics Clin Appl
; 12(3): e1700067, 2018 05.
Article
in English
| MEDLINE | ID: mdl-29281176
20.
Development of a Protein Biomarker Panel to Detect Non-Small-Cell Lung Cancer in Korea.
Clin Lung Cancer
; 18(2): e99-e107, 2017 03.
Article
in English
| MEDLINE | ID: mdl-27836219